| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.003 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.008 |